P26 Asociación entre diabetes y depresión en una población con diabetes mellitus 2 tratada en un centro de referencia

Introduction: The diabetes mellitus 2 (DM2) is considered one of the more demanding psychological chronic diseases. The presence of depressive symptoms is a known comorbidity in patients with diabetes mellitus (1 and 2), being up to three times higher than in the non-diabetic population. Depression is associated with poorer outcomes on metabolic control, adherence to treatment, higher morbidity, and higher health care costs. Objectives: To know the prevalence of depression and its relationship with metabolic control, chronic complications, sociocultural factors and adherence to treatment. Methods: A descriptive observational study was conducted during the period May-July 2020. Patients over 15 years old with diagnostic of DM2 who attend the Teaching Care Unit of diabetes in Pasteur Hospital were included. To evaluate depressive symptoms, we applied the Lico Beck Inventory II (BDI-II), which consists of 21 questions and whose score ranges from 0 to 63, with "depression" being equal or greater than 14. It was divided into mild symptoms 14-19, moderate 20-28 and severe 29-63. To evaluate adherence to the treatment, the Morisky Green test was used. This study was conducted in a period of pandemic by COVID-19. The chi -aquare test was used to investigate the association between categorical variables and Spearman’s r to investigate the correlation between quantitative variables. The comparison of quantitative variables in two groups was performed using the Mann Whitney test and , when more than two groups were compared, the Kruskal Wallis test. P values lower than 5% were considerer significant.